Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Abroad (travel likely)RecruitingPHASE2

Conditions

TNBC - Triple-Negative Breast Cancer · Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cedars-Sinai Medical Center, Los Angeles, California, United States
Contact: Study coordinator (Clinical Trial Recruitment Navigator) · cancer.trial.info@cshs.org

Study leads

Stephen L Shiao, MD, PhD
Principal Investigator
CSMC

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Breast Neoplasms · Breast Cancer · Breast Tumors

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Scottsdale, United States

A Study of Pembrolizumab and Cryoablation in People With Breast Cancer

Metastatic Breast Cancer · Breast Cancer · Breast Cancer Stage IV

Abroad (travel likely)RecruitingPHASE1

Basking Ridge, United States · Middletown, United States

Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK

Triple-negative Breast Cancer · TNBC - Triple-Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Aarau, Switzerland · Basel, Switzerland

PSMA-PET/CT to Assess the Expression of Specific Membrane Antigen (PSMA) in Patients With Progressive Triple-negative Breast Cancer.

TNBC - Triple-Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Brussels, Belgium